Cray/Media:      Mardi Larson, 612-683-3538
Cray/Financial:  Bill Gacki, 612-683-7372

TAISHO PHARMACEUTICAL CO. LTD IS CRAY RESEARCH'S
FIRST CUSTOMER IN JAPANESE PHARMACEUTICAL
INDUSTRY

EAGAN, Minn., April 13, 1994 -- Cray Research, Inc. (NYSE:CYR)
today announced the company's first order from a Japanese
pharmaceutical firm.  Taisho Pharmaceutical Co., Ltd. has
installed a CRAY EL92 departmental supercomputer system at
Taisho's general research laboratory in Omiya City, Saitama
Prefecture.  Terms were not disclosed.

Taisho will use the CRAY EL92 system as a high-speed server
linked to database servers and graphic workstations to run
proprietary and leading third-party applications software,
including Gaussian, AMBER, MOPAC and Cray Research's
integrated UniChem software for molecular design.   Taisho
conducts comprehensive studies on the interaction between bio-
molecules and will use the CRAY EL92 system in the
development of new drugs. 

Although Cray Research supercomputers are used within
Japan's chemical industry, this pharmaceutical-industry order
is a first in Japan.  Cray Research supercomputer systems can
substantially accelerate the design of drugs and other
substances, the company said.

The two-processor, air-cooled deskside supercomputer system
ordered from Cray Research Japan features a peak system
performance of 267 megaflops (million calculations per
second), 512 megabytes (million bytes) of main memory, and
measures just 2 feet (w) x 2.2 feet (d) x 4.6 feet (h).

Taisho chose the CRAY EL92 system for its high-capacity
UNICOS (UNIX) operating system and wide range of available
applications software programs.

Cray Research provides the leading supercomputing tools and
services to help solve our customers' most challenging
problems.
       
###